NCT01601197

Brief Summary

Immunization injections are a significant source of pain for infants. Tactile stimulation (rubbing/applying pressure) may be an effective and feasible pain-relieving intervention - it is cost neutral, and has been shown to be effective in children and adults undergoing injections. The aim of this study is to determine the added benefit of tactile stimulation when added to other proven analgesic interventions during routine infant immunization injections.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 2012

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 17, 2012

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

October 24, 2012

Status Verified

October 1, 2012

Enrollment Period

7 months

First QC Date

May 13, 2012

Last Update Submit

October 23, 2012

Conditions

Keywords

immunizationpain managementinfantstactile stimulation

Outcome Measures

Primary Outcomes (1)

  • Infant Pain as assessed by the Modified Behavioral Pain Scale

    assessed from videotaped procedure

    First 15 seconds after injection

Secondary Outcomes (3)

  • Parent rating of infant pain using the Numerical Rating Scale

    first minute after injection

  • Immunizer rating of infant pain using the Numerical Rating Scale

    first minute after injection

  • Infant crying time

    duration of crying after injection

Study Arms (2)

Tactile stimulation

EXPERIMENTAL

Ipsilateral limb will be rubbed immediately before, during and after immunization injection(s)

Behavioral: Tactile stimulation

No tactile stimulation

NO INTERVENTION

There will be no tactile stimulation of ipsilateral limb before, during and after immunization injection(s)

Interventions

Immunizer will rub the ipsilateral limb before, during and after immunization injection(s)

Tactile stimulation

Eligibility Criteria

Age1 Month - 12 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • infants 1-12 months of age receiving routine immunization injections in an outpatient pediatric clinic in Toronto

You may not qualify if:

  • impaired neurological development
  • history of seizure
  • use of topical anesthetics
  • use of sedatives or narcotics within 24 hours
  • fever or illness that would prevent administration of vaccine
  • prior participation in the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Tommy Ho Pediatric Clinic

Toronto, Ontario, M5G 1Z6, Canada

RECRUITING

Related Publications (1)

  • Taddio A, Ho T, Vyas C, Thivakaran S, Jamal A, Ilersich AF, Hogan ME, Shah V. A randomized controlled trial of clinician-led tactile stimulation to reduce pain during vaccination in infants. Clin Pediatr (Phila). 2014 Jun;53(7):639-44. doi: 10.1177/0009922814526976. Epub 2014 Mar 14.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anna Taddio, PhD

    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2 Canada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mary-Ellen Hogan, PharmD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Leslie Dan Faculty of Pharmacy

Study Record Dates

First Submitted

May 13, 2012

First Posted

May 17, 2012

Study Start

May 1, 2012

Primary Completion

December 1, 2012

Study Completion

May 1, 2013

Last Updated

October 24, 2012

Record last verified: 2012-10

Locations